Bruker Announces New D6 PHASERTM Benchtop X-Ray Diffraction (XRD) Platform for Materials Analysis and Advanced Research

KARLSRUHE, Germany–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR), the global leader in X-ray diffraction, today announces the new D6 PHASERTM X-Ray Diffraction (XRD) system. The D6 PHASER is a new benchtop XRD platform designed with the analytical flexibility typically only available in larger, floor-standing systems. Unlike conventional, more limited benchtop XRD instruments, the D6 PHASER enables... Read more

Danaher Schedules Second Quarter 2023 Earnings Conference Call

WASHINGTON, June 20, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2023 on Tuesday, July 25, 2023 beginning at 8:00 a.m. ET and lasting approximately 1 hour. During the call, the company will discuss its financial performance, as well as future expectations. The... Read more

Bruker Releases 2023 Sustainability Report

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today released its 2023 Sustainability Report, highlighting how Bruker’s spirit of ‘Innovation with Integrity’ is advancing science and technology, medicine and health, as well as safety and prosperity in a responsible, sustainable manner. The report also provides an overview of Bruker’s ESG strategy, initiatives and performance. Bruker 2023... Read more

Bruker Introduces Novel EVOQ™ DART-TQ+ for Chromatography-Free Mass Spectrometry Aimed at the Applied Market Segments

New EVOQ DART-TQ+ system for chromatography-free triple-quadrupole mass spectrometry for point-of-need (PoN) routine analysis Launch of impact™ II VIP ESI-TOF (time of flight) system for highest sensitivity New TargetScreener™ 4D software bringing the selectivity of TIMS (trapped ion mobility spectrometry) to high-confidence analyte screening and quantitation HOUSTON–(BUSINESS WIRE)– At the 71st ASMS meeting, Bruker Corporation... Read more

Bruker Launches timsTOF Ultra Mass Spectrometer with Transformative Sensitivity, 300 Hz PASEF MS/MS, and VistaScan™ for Enhanced dia-PASEF® 4D-Proteomics™

timsTOF Ultra Further Advances Quantitative Spatial and Single-cell 4D-Proteomics and 4D-Lipidomics™, Immunopeptidomics, PTM and Protein-Protein Interactions Analysis – with Speed and Robustness timsTOF Ultra mass spectrometer enables ID of >5000 protein groups and >55k peptides at single-cell sensitivity (0.125 ng) with highest confidence at <1% False Discovery Rate New CSI Ultra ion source with vortex... Read more

PreOmics Introduces New ENRICH-iST Kits and Novel Workflow for Unbiased, Affordable Plasma and Serum Proteomics by LC-MS

ENRICH-iST enables unbiased enrichment of lower abundant plasma and serum proteins by 50% to more than 100% in human and rodent plasma proteomics in a cost-effective, fast 5-hour workflow ENRICH-iST utilizes non-functionalized paramagnetic microbeads supporting automated platforms ENRICH-iST enables protein enrichment and tryptic digestion on only 20 microL of starting material HOUSTON–(BUSINESS WIRE)– At ASMS... Read more

Bruker Corporation to Present at Jefferies 2023 Healthcare Conference

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will present at the Jefferies 2023 Healthcare Conference in New York on Friday, June 9, 2023 at 9:00 am EDT. Presenting for the company will be Juergen Srega, President of the Bruker CALID Group. A live audio webcast of the presentation will be available on... Read more

Bruker to Host Investor Day on June 15th, 2023

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the Company will host an Investor Day on June 15th, 2023, starting at 10:00 AM EDT, at Bruker’s Headquarters located at 40 Manning Road, Billerica, MA, with the live webcast starting at 11:00 AM EDT. Bruker’s 2023 Investor Day will provide a deeper look into the... Read more